Senator Cynthia Lummis Says ‘SEC Cannot Continue Ruling By Enforcement’ Following Kraken Lawsuit

Senator Cynthia Lummis (R-Wyo.), on Tuesday, criticized the Securities and Exchange Commission for its current approach to crypto regulation, arguing that the agency often resorts to “ruling by enforcement”.

Senator Cynthia Lummis (R-Wyo.), on Tuesday, criticized the Securities and Exchange Commission for its current approach to crypto regulation, arguing that the agency often resorts to “ruling by enforcement”.

What Happened: Lummis expressed her disapproval on X, formerly Twitter, arguing that crypto asset companies seeking guidance from the SEC are instead faced with enforcement actions that not only lack a clear basis but also harm consumers. 

“The SEC cannot continue ruling by enforcement. Crypto asset companies have repeatedly tried to get guidance from the SEC only to be hit with enforcement actions, causing unnecessary harm to consumers,” stated Lummis. She believes that it’s Congress’ responsibility to establish a regulatory framework that clarifies what constitutes a security and what is considered a commodity.

See More: Dogecoin HODLERs Are Beating Shiba Inu With 57% Landing In Profits, IntoTheBlock Data Reveals

Why It Matters: The SEC launched a lawsuit against crypto exchange Kraken, alleging the commingling of customer and corporate funds. The suit claims that Kraken, while operating as an unregistered broker, clearing agency, and dealer, violated federal securities laws.

According to the SEC, Kraken’s actions have put customers at “significant risk” by mixing up to $33 billion in customer crypto assets with its corporate funds. This information was bolstered by a statement from Kraken’s independent auditor, as cited by the federal regulator.

Photo Courtesy: Wikimedia Commons

Price Action: At the time of writing, Bitcoin (CRYPTO: BTC) was trading at $37,600, up 1% in the last 24 hours according to Benzinga Pro.

Read Next: Here’s How Much You Should Invest In Shiba Inu Today For A $1M Payday If SHIB Hits 1 Cent?

Total
0
Shares
Related Posts
Read More

SEC Green Lights Public Listing Of Texas Cannabis Co. That Will Use AI In Clinical Trials

Cannabis Bioscience, a Houston-based clinical research company, has announced plans to conduct cannabis clinical trials using artificial intelligence (AI) programs. The company aims to optimize the research processes and promote the use of cannabinoid therapies as a first option for patients. Proceeds from a stock offering by selling shareholders will be used to fund these trials.

CBIH

Read More

What’s Going On With AMC Entertainment Stock?

AMC shares continue their recent rally on Monday in spite of a lack of company specific news. Last Thursday, Wedbush analyst Alicia Reese maintained a Neutral rating on AMC Entertainment and lowered the price target from $6 to $4, citing the company's heavy debt load overshadowing positives including improving box office trends.

AMC